| Intrepid Usa Healthcare Services | |
| 400 Poplar Street, 2nd Floor, Terre Haute, Indiana 47807 | |
| (812) 232-0725 | |
| Name | Intrepid Usa Healthcare Services |
|---|---|
| Location | 400 Poplar Street, 2nd Floor, Terre Haute, Indiana |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 157530 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 46105, 46120, 46121, 46128, 46135, 46171, 46172, 46175, 47401, 47403, 47404, 47424, 47427, 47429, 47431, 47433, 47438, 47441, 47456, 47459, 47460, 47464, 47465, 47468, 47471, 47802, 47803, 47804, 47805, 47807, 47832, 47833, 47834, 47836, 47837, 47838, 47840, 47841, 47842, 47846, 47847, 47848, 47850, 47853, 47857, 47858, 47860, 47861, 47862, 47863, 47866, 47868, 47872, 47874, 47875, 47879, 47881, 47882, 47884, 47885, 47928, 47932, 47933, 47940, 47954, 47974, 47989 |
| NPI Number | 1205818846 |
| Organization Name | INTREPID OF INDIANA, INC. |
| Doing Business As | INTREPID USA HEALTHCARE SERVICES |
| Address | 2901 Ohio Blvd Ste 210-1, Terre Haute, IN 47803 |
| Phone Number | 812-232-0725 |
News Archive
A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) had significantly worse educational, occupational, economic and social outcomes in a 33-year follow-up study compared to men who were not diagnosed.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
Neogenix Oncology, Inc. is pleased to announce it has signed an agreement with Cambridge Biomedical, Inc, based in Boston, MA, for the development of its pancreatic and colorectal cancer diagnostic serum ELISA assays.
An international research collaboration has discovered a new bacteria-killing toxin that shows promise of impacting superbug infectious diseases.
During the last thirty years there has been an increase in the number of babies born by Caesarean section. New research published in BioMed Central's open access journal BMC Public Health shows that there has also been a change in the social and economic status of the mothers involved and that advantaged mothers are more likely to have their babies by Caesarean section than mothers living in more difficult circumstances.
› Verified 8 days ago
| Quality Rating: |
News Archive
A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) had significantly worse educational, occupational, economic and social outcomes in a 33-year follow-up study compared to men who were not diagnosed.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
Neogenix Oncology, Inc. is pleased to announce it has signed an agreement with Cambridge Biomedical, Inc, based in Boston, MA, for the development of its pancreatic and colorectal cancer diagnostic serum ELISA assays.
An international research collaboration has discovered a new bacteria-killing toxin that shows promise of impacting superbug infectious diseases.
During the last thirty years there has been an increase in the number of babies born by Caesarean section. New research published in BioMed Central's open access journal BMC Public Health shows that there has also been a change in the social and economic status of the mothers involved and that advantaged mothers are more likely to have their babies by Caesarean section than mothers living in more difficult circumstances.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 99.8 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 98.1 | 98.6 |
| How often the home health team checked patients’ risk of falling | 98.8 | 99.6 |
| How often the home health team checked patients for depression | 99.8 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 78.5 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 78.4 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 92.6 | 96.4 |
News Archive
A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) had significantly worse educational, occupational, economic and social outcomes in a 33-year follow-up study compared to men who were not diagnosed.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
Neogenix Oncology, Inc. is pleased to announce it has signed an agreement with Cambridge Biomedical, Inc, based in Boston, MA, for the development of its pancreatic and colorectal cancer diagnostic serum ELISA assays.
An international research collaboration has discovered a new bacteria-killing toxin that shows promise of impacting superbug infectious diseases.
During the last thirty years there has been an increase in the number of babies born by Caesarean section. New research published in BioMed Central's open access journal BMC Public Health shows that there has also been a change in the social and economic status of the mothers involved and that advantaged mothers are more likely to have their babies by Caesarean section than mothers living in more difficult circumstances.
› Verified 8 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 75.5 | 79.6 |
| How often patients got better at getting in and out of bed | 76.5 | 81.1 |
| How often patients got better at bathing | 77.9 | 82.3 |
| How often patients’ breathing improved | 64.7 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 94.7 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 75.2 | 75 |
| How often home health patients had to be admitted to the hospital | 13.2 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 14.8 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 96.5 | 94 |
News Archive
A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) had significantly worse educational, occupational, economic and social outcomes in a 33-year follow-up study compared to men who were not diagnosed.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
Neogenix Oncology, Inc. is pleased to announce it has signed an agreement with Cambridge Biomedical, Inc, based in Boston, MA, for the development of its pancreatic and colorectal cancer diagnostic serum ELISA assays.
An international research collaboration has discovered a new bacteria-killing toxin that shows promise of impacting superbug infectious diseases.
During the last thirty years there has been an increase in the number of babies born by Caesarean section. New research published in BioMed Central's open access journal BMC Public Health shows that there has also been a change in the social and economic status of the mothers involved and that advantaged mothers are more likely to have their babies by Caesarean section than mothers living in more difficult circumstances.
› Verified 8 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) had significantly worse educational, occupational, economic and social outcomes in a 33-year follow-up study compared to men who were not diagnosed.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
Neogenix Oncology, Inc. is pleased to announce it has signed an agreement with Cambridge Biomedical, Inc, based in Boston, MA, for the development of its pancreatic and colorectal cancer diagnostic serum ELISA assays.
An international research collaboration has discovered a new bacteria-killing toxin that shows promise of impacting superbug infectious diseases.
During the last thirty years there has been an increase in the number of babies born by Caesarean section. New research published in BioMed Central's open access journal BMC Public Health shows that there has also been a change in the social and economic status of the mothers involved and that advantaged mothers are more likely to have their babies by Caesarean section than mothers living in more difficult circumstances.
› Verified 8 days ago
The patient survey data of Intrepid Usa Healthcare Services is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 88 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 88 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 82 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 86 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 77 | 78 |
News Archive
A new study conducted by researchers at the Child Study Center at NYU Langone Medical Center found men diagnosed as children with attention-deficit/hyperactivity disorder (ADHD) had significantly worse educational, occupational, economic and social outcomes in a 33-year follow-up study compared to men who were not diagnosed.
AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.
Neogenix Oncology, Inc. is pleased to announce it has signed an agreement with Cambridge Biomedical, Inc, based in Boston, MA, for the development of its pancreatic and colorectal cancer diagnostic serum ELISA assays.
An international research collaboration has discovered a new bacteria-killing toxin that shows promise of impacting superbug infectious diseases.
During the last thirty years there has been an increase in the number of babies born by Caesarean section. New research published in BioMed Central's open access journal BMC Public Health shows that there has also been a change in the social and economic status of the mothers involved and that advantaged mothers are more likely to have their babies by Caesarean section than mothers living in more difficult circumstances.
› Verified 8 days ago
Visiting Nurse Association Of The Wabash Valley In Location: 400 8th Ave, Terre Haute, Indiana 47804 Ratings: Phone: (812) 232-7611 | |
Intrepid Usa Healthcare Services Location: 400 Poplar Street, 2nd Floor, Terre Haute, Indiana 47807 Ratings: Phone: (812) 232-0725 |